Philip H. Coelho - 24 Aug 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Philip H. Coelho
Issuer symbol
CPRX
Transactions as of
24 Aug 2021
Transactions value $
-$1,780
Form type
4
Filing time
26 Aug 2021, 16:45:14 UTC
Previous filing
25 May 2021
Next filing
15 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $52K +16.7K +7.69% $3.12 233K 24 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$52.9K -9.49K -4.07% $5.58 224K 24 Aug 2021 Direct F1
transaction CPRX Common stock, par value $0.001 per share Options Exercise $52K +16.7K +7.44% $3.12 241K 25 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$52.8K -9.5K -3.95% $5.56 231K 25 Aug 2021 Direct F1
transaction CPRX Common stock, par value $0.001 per share Options Exercise $52K +16.7K +7.21% $3.12 248K 26 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$49.3K -9.04K -3.65% $5.45 239K 26 Aug 2021 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale -$2.75K -504 -0.21% $5.46 238K 26 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -16.7K -4.68% $0.00 340K 24 Aug 2021 Common Stock 16.7K $3.12 Direct F2
transaction CPRX Options to purchase common stock Options Exercise $0 -16.7K -4.91% $0.00 323K 25 Aug 2021 Common Stock 16.7K $3.12 Direct F2
transaction CPRX Options to purchase common stock Options Exercise $0 -16.7K -5.16% $0.00 306K 26 Aug 2021 Common Stock 16.7K $3.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover exercise price of options.
F2 Options vested in two annual tranches beginning on August 28, 2014.